Patient recruitment is one of the main bottlenecks in global clinical research: months of delays, manual processes tedious, and trials that struggle to find the right participants at the right time. Every lost day means a potential treatment is delayed in reaching patients who need it. PatLynk addresses this hurdle with a platform powered by AI that automatically matches automatically patients to trials, generates pre-screening and enrollment documents, and supports physicians and sponsors from initial contact to identifying better-suited participants - in days rather than months.
The next step
Launched last October with 20 beta users, PatLynk has already seen encouraging organic traction - over 30 visits per day on average, without marketing effort. Encouraged by this feedback, they are currently developing version V1 of the platform, with the ambition to transform this initial momentum into structured growth.
Why 21st by CentraleSupélec?
At this stage of development, the right questions are as valuable as the right answers. PatLynk is joining 21st by CentraleSupélec to be guided in the right direction and benefit from the experience of other startups who have faced the same challenges – a valuable anchor for making the right decisions at the right time.
Focus on the co-founders
#clinicaltrials #patientcentricity #AI #patientrecruitment #medicalinnovationaccess
.avif)
